Published in Cancer Inform on October 13, 2014
Phenome-driven disease genetics prediction toward drug discovery. Bioinformatics (2015) 0.91
Disease Comorbidity Network Guides the Detection of Molecular Evidence for the Link Between Colorectal Cancer and Obesity. AMIA Jt Summits Transl Sci Proc (2015) 0.81
Phenome-based gene discovery provides information about Parkinson's disease drug targets. BMC Genomics (2016) 0.77
Insights into Population Health Management Through Disease Diagnoses Networks. Sci Rep (2016) 0.75
Interrogating Patient-level Genomics and Mouse Phenomics towards Understanding Cytokines in Colorectal Cancer Metastasis. AMIA Jt Summits Transl Sci Proc (2017) 0.75
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med (2003) 35.39
Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature (2012) 16.13
Network medicine: a network-based approach to human disease. Nat Rev Genet (2011) 14.07
The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med (1995) 11.08
A human phenome-interactome network of protein complexes implicated in genetic disorders. Nat Biotechnol (2007) 9.90
Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA (2004) 5.93
Colorectal cancer epidemiology: incidence, mortality, survival, and risk factors. Clin Colon Rectal Surg (2009) 5.38
Insulin, insulin-like growth factors and colon cancer: a review of the evidence. J Nutr (2001) 5.16
Network-based global inference of human disease genes. Mol Syst Biol (2008) 5.01
The insulin and insulin-like growth factor receptor family in neoplasia: an update. Nat Rev Cancer (2012) 4.72
Depression and anxiety in women with early breast cancer: five year observational cohort study. BMJ (2005) 4.47
Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr (2004) 4.37
Discovery of drug mode of action and drug repositioning from transcriptional responses. Proc Natl Acad Sci U S A (2010) 4.35
Probing genetic overlap among complex human phenotypes. Proc Natl Acad Sci U S A (2007) 3.79
Associating genes and protein complexes with disease via network propagation. PLoS Comput Biol (2010) 3.65
A dynamic network approach for the study of human phenotypes. PLoS Comput Biol (2009) 3.62
Insulin and colon cancer. Cancer Causes Control (1995) 3.48
Stress, depression, the immune system, and cancer. Lancet Oncol (2004) 3.48
Prospective study of adult onset diabetes mellitus (type 2) and risk of colorectal cancer in women. J Natl Cancer Inst (1999) 3.22
PREDICT: a method for inferring novel drug indications with application to personalized medicine. Mol Syst Biol (2011) 3.22
From syndrome families to functional genomics. Nat Rev Genet (2004) 2.86
Association of the autoimmune disease scleroderma with an immunologic response to cancer. Science (2013) 2.46
A nondegenerate code of deleterious variants in Mendelian loci contributes to complex disease risk. Cell (2013) 2.28
The impact of cellular networks on disease comorbidity. Mol Syst Biol (2009) 2.23
Using electronic patient records to discover disease correlations and stratify patient cohorts. PLoS Comput Biol (2011) 2.14
Reduced risk of colorectal cancer with use of oral bisphosphonates: a systematic review and meta-analysis. J Clin Oncol (2012) 2.09
Genome-wide inferring gene-phenotype relationship by walking on the heterogeneous network. Bioinformatics (2010) 1.88
Phenome connections. Trends Genet (2008) 1.84
The impact of comorbidity on cancer survival: a review. Clin Epidemiol (2013) 1.68
Anxiety in cancer patients. Br J Cancer (2000) 1.67
Depression as a risk factor for cancer: renewing a debate on the psychobiology of disease. J Natl Cancer Inst (1998) 1.46
A phenomics-based strategy identifies loci on APOC1, BRAP, and PLCG1 associated with metabolic syndrome phenotype domains. PLoS Genet (2011) 1.35
Stress and depression-induced immune dysfunction: implications for the development and progression of cancer. Int Rev Psychiatry (2005) 1.24
Insulin resistance and its contribution to colon carcinogenesis. Exp Biol Med (Maywood) (2003) 1.23
Type 2 diabetes mellitus as risk factor for colorectal cancer. Arch Physiol Biochem (2008) 1.15
Linking genes to diseases: it's all in the data. Genome Med (2009) 1.14
Type 2 diabetes mellitus and the risk of colorectal cancer. Clin Gastroenterol Hepatol (2005) 1.12
Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders. Nat Rev Neurosci (2013) 1.11
Cancer incidence in a sample of Maryland residents with serious mental illness. Psychiatr Serv (2012) 1.05
Epilepsy meets cancer: when, why, and what to do about it? Lancet Oncol (2012) 1.03
Molecular evidence for the inverse comorbidity between central nervous system disorders and cancers detected by transcriptomic meta-analyses. PLoS Genet (2014) 1.00
Age, comorbidity, treatment decision and prognosis in lung cancer. Age Ageing (2008) 0.99
Association of angiopoietin-2, C-reactive protein and markers of obesity and insulin resistance with survival outcome in colorectal cancer. Br J Cancer (2010) 0.97
Obesity, inflammatory signaling, and hepatocellular carcinoma-an enlarging link. Cancer Cell (2010) 0.92
Cancer and depression: cancer presenting with depressive illness: an autoimmune disease? Br J Psychiatry (1982) 0.89
Epilepsy in the cancer patient. Cancer Chemother Pharmacol (2011) 0.87
Osteoporosis is associated with the risk of colorectal adenoma in women. Dis Colon Rectum (2013) 0.82
Mining patterns of adverse events using aggregated clinical trial results. AMIA Jt Summits Transl Sci Proc (2013) 0.81
Cancer. Can cancer trigger autoimmunity? Science (2014) 0.78